Development of outcome measures for large-vessel vasculitis for use in clinical trials: Opportunities, challenges, and research agenda

Haner Direskeneli, Sibel Z. Aydin, Tanaz A. Kermani, Eric Lawrence Matteson, Maarten Boers, Karen Herlyn, Raashid A. Luqmani, Tuhina Neogi, Philip Seo, Ravi Suppiah, Gunnar Tomasson, Peter A. Merkel

Research output: Contribution to journalArticle

68 Scopus citations
Original languageEnglish (US)
Pages (from-to)1471-1479
Number of pages9
JournalJournal of Rheumatology
Volume38
Issue number7
DOIs
StatePublished - Jul 2011

    Fingerprint

Keywords

  • Giant cell arteritis
  • Outcomes
  • Takayasu's arteritis
  • Vasculitis

ASJC Scopus subject areas

  • Rheumatology
  • Immunology
  • Immunology and Allergy

Cite this

Direskeneli, H., Aydin, S. Z., Kermani, T. A., Matteson, E. L., Boers, M., Herlyn, K., Luqmani, R. A., Neogi, T., Seo, P., Suppiah, R., Tomasson, G., & Merkel, P. A. (2011). Development of outcome measures for large-vessel vasculitis for use in clinical trials: Opportunities, challenges, and research agenda. Journal of Rheumatology, 38(7), 1471-1479. https://doi.org/10.3899/jrheum.110275